首页> 美国卫生研究院文献>other >Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma
【2h】

Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma

机译:基于体积的F-18 FDG PET / CT成像标志物可为高级骨或软组织肉瘤患者的组织学分级提供补充预后信息

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the study is to assess the prognostic value of different volume-based calculations of tumor metabolic activity in the initial assessment of patients with high-grade bone sarcomas (BS) and soft tissue sarcomas (STS) using F-18 FDG PET/CT.A single-site, retrospective study from 2002 to 2012 including 92 patients with histologically verified high-grade BS (N = 37) or STS (N = 55). All patients underwent a pretreatment F-18 FDG PET/CT scan. Clinical data were registered. Measurements of the accuracy of metabolic tumor volume with a preset threshold of 40% of the maximum standardized uptake value of primary tumor (MTV40%) and total lesion glycolysis (TLG) as prognostic variables and identification of optimal discriminating cut-off values were performed through ROC curve analysis. Patients were grouped according to the cut-off values. All deaths were considered an event in survival analysis. Kaplan–Meier survival estimates and log-rank test were used to compare the degree of equality of survival distributions. Prognostic variables with related hazard ratios (HR) were assessed using Cox proportional hazards regression analysis.Forty-one of 92 patients died during follow-up (45%; 12 BS and 29 STS). Average survival for included patients was 6.5 years (95% CI 5.8–7.3 years) and probability of 5-year survival was 52%. There was a high-significant accuracy of TLG and MTV40% as prognostic variables when looking on all patients and during subgroup analysis. AUCs were higher for TLG than for MTV40%. TLG above optimal cut-off value was the only variable which was independently prognostic for survival throughout multivariate regression analysis of all included patients (P = 0.01, HR 4.78 [95% CI 1.45–15.87]) and subgroup analysis (BS: P = 0.04, HR 11.11 [95% CI 1.09–111.11]; STS: P < 0.05, HR 3.37 [95% CI 1.02–11.11]). No significant results were demonstrated for MTV40%.Volume-based F-18 FDG PET/CT imaging markers in terms of pretreatment estimation of TLG provide supplemental prognostic information to histologic grading, with significant independent properties for prediction of overall survival in patients with high-grade BS or STS.
机译:这项研究的目的是评估在使用F-18 FDG PET / E对高级别骨肉瘤(BS)和软组织肉瘤(STS)的患者进行初始评估时,基于体积的不同肿瘤代谢活性计算的预后价值。 CT.2002年至2012年的一项单点回顾性研究,包括92例经组织学证实为高级别BS(N = 37)或STS(N = 55)的患者。所有患者均接受F-18 FDG PET / CT预处理扫描。登记临床数据。通过以下方法测量代谢性肿瘤体积的准确性,该阈值以原发性肿瘤最大标准摄取值的40%(MTV40%)和总病变糖酵解(TLG)作为预后变量的标准阈值进行确定,并确定最佳区分阈值ROC曲线分析。根据截止值将患者分组。在生存分析中,所有死亡均视为事件。 Kaplan–Meier生存估计和对数秩检验用于比较生存分布的均等程度。使用Cox比例风险回归分析评估了具有相关危险比(HR)的预后变量.92名患者中有41名在随访期间死亡(45%; 12名BS和29名STS)。纳入患者的平均生存期为6.5年(95%CI 5.8–7.3年),5年生存率为52%。在所有患者中以及亚组分析期间,TLG和MTV40%作为预后变量具有很高的准确性。 TLG的AUC高于MTV40%。在所有纳入患者(P = 0.01,HR 4.78 [95%CI 1.45–15.87])和亚组分析(BS:P = 0.04)的多变量回归分析中,TLG高于最佳临界值是唯一能够独立预测生存的变量。 ,HR 11.11 [95%CI 1.09–111.11]; STS:P 0.05,HR 3.37 [95%CI 1.02-11.11])。对于MTV40%,未显示明显结果。基于体积的F-18 FDG PET / CT影像学标志物在TLG的治疗前估计方面可为组织学分级提供补充的预后信息,并具有显着的独立性,可预测高危患者的总生存期BS或STS级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号